Dana Investment Advisors Inc. Has $11.24 Million Holdings in Zoetis Inc. (NYSE:ZTS)

Dana Investment Advisors Inc. boosted its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 10.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 68,953 shares of the company’s stock after buying an additional 6,733 shares during the quarter. Dana Investment Advisors Inc.’s holdings in Zoetis were worth $11,235,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of ZTS. Atlantic Edge Private Wealth Management LLC increased its position in Zoetis by 482.8% during the fourth quarter. Atlantic Edge Private Wealth Management LLC now owns 169 shares of the company’s stock worth $28,000 after buying an additional 140 shares during the last quarter. Darwin Wealth Management LLC acquired a new position in Zoetis during the third quarter worth approximately $31,000. First Personal Financial Services acquired a new position in Zoetis during the third quarter worth approximately $33,000. Capital Performance Advisors LLP acquired a new position in Zoetis during the third quarter worth approximately $33,000. Finally, Dunhill Financial LLC increased its position in Zoetis by 80.6% during the third quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock worth $33,000 after buying an additional 75 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Insider Activity

In other news, EVP Roxanne Lagano sold 326 shares of the stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $171.18, for a total value of $55,804.68. Following the completion of the transaction, the executive vice president now directly owns 16,107 shares in the company, valued at approximately $2,757,196.26. This represents a 1.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.16% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on ZTS shares. StockNews.com downgraded Zoetis from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. Stifel Nicolaus decreased their target price on Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. Piper Sandler upped their target price on Zoetis from $200.00 to $205.00 and gave the company an “overweight” rating in a research report on Thursday, February 27th. Leerink Partners started coverage on Zoetis in a research report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 target price on the stock. Finally, Barclays upped their target price on Zoetis from $242.00 to $244.00 and gave the company an “overweight” rating in a research report on Friday, February 14th. Two equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $215.90.

Zoetis Stock Down 1.7 %

NYSE ZTS opened at $166.96 on Thursday. The business has a fifty day moving average price of $166.57 and a two-hundred day moving average price of $176.99. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.75 and a quick ratio of 1.08. Zoetis Inc. has a fifty-two week low of $144.80 and a fifty-two week high of $200.33. The stock has a market capitalization of $74.76 billion, a PE ratio of 30.52, a PEG ratio of 2.78 and a beta of 0.94.

Zoetis (NYSE:ZTS) last released its earnings results on Thursday, February 13th. The company reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.03. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. The firm had revenue of $2.32 billion during the quarter, compared to analysts’ expectations of $2.30 billion. Equities analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.20%. The ex-dividend date of this dividend is Monday, April 21st. Zoetis’s payout ratio is 36.56%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.